Novocure announced positive results today from the Phase 2 PANOVA-4 trial of Tumor Treating Fields (TTFields) therapy. Read more in our press release: https://t.co/42QnnbK1lD
The U.S. Food and Drug Administration (FDA) has approved Novocure’s treatment for adult patients with locally advanced pancreatic cancer concurrently with gemcitabine and nab-paclitaxel.
https://t.co/bo8nPXHSwB
Novocure today announced it submitted an application to the U.S. Food and Drug Administration (FDA) for the approval of Tumor Treating Fields (TTFields) therapy for the treatment of locally advanced pancreatic cancer. Read more: https://t.co/TDOvp6F2oE
The phase 3 METIS clinical trial in brain metastases from non-small cell lung cancer following stereotactic radiosurgery met its primary endpoint. https://t.co/b7wWjnviE7 #oncology#clinicaltrials